| Adaptation of the hydrocarbonoclastic bacterium Alcanivorax borkumensis SK2 to alkanes and toxic organic compounds: a physiological and transcriptomic approach DJ Naether, S Slawtschew, S Stasik, M Engel, M Olzog, LY Wick, ... Applied and environmental microbiology 79 (14), 4282-4293, 2013 | 98 | 2013 |
| CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome F Taube, JA Georgi, M Kramer, S Stasik, JM Middeke, C Röllig, U Krug, ... Blood, The Journal of the American Society of Hematology 139 (1), 87-103, 2022 | 95 | 2022 |
| TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas: A Pilot Prospective Study TA Juratli, S Stasik, A Zolal, C Schuster, S Richter, D Daubner, MA Juratli, ... Clinical Cancer Research 24 (21), 5282-5291, 2018 | 73 | 2018 |
| Anaerobic BTEX degradation in oil sands tailings ponds: impact of labile organic carbon and sulfate-reducing bacteria S Stasik, LY Wick, K Wendt-Potthoff Chemosphere 138, 133-139, 2015 | 57 | 2015 |
| Understanding biogeochemical gradients of sulfur, iron and carbon in an oil sands tailings pond S Stasik, N Loick, K Knöller, C Weisener, K Wendt-Potthoff Chemical Geology 382, 44-53, 2014 | 57 | 2014 |
| An optimized targeted next-generation sequencing approach for sensitive detection of single nucleotide variants S Stasik, C Schuster, C Ortlepp, U Platzbecker, M Bornhäuser, J Schetelig, ... Biomolecular Detection and Quantification 15, 6-12, 2018 | 48 | 2018 |
| Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer S Stasik, K Salomo, U Heberling, M Froehner, U Sommer, GB Baretton, ... Clinical Biochemistry 64, 60-63, 2019 | 45 | 2019 |
| Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents AS Kubasch, F Schulze, A Giagounidis, KS Götze, J Krönke, K Sockel, ... Leukemia 34 (4), 1182-1186, 2020 | 44 | 2020 |
| Interaction of microbial sulphate reduction and methanogenesis in oil sands tailings ponds S Stasik, K Wendt-Potthoff Chemosphere 103, 59-66, 2014 | 41 | 2014 |
| EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia S Stasik, JM Middeke, M Kramer, C Röllig, A Krämer, S Scholl, ... Haematologica 105 (5), e228, 2020 | 36 | 2020 |
| Profiling of aberrant DNA methylation in acute myeloid leukemia reveals subclasses of CG-rich regions with epigenetic or genetic association C Gebhard, D Glatz, L Schwarzfischer, J Wimmer, S Stasik, M Nuetzel, ... Leukemia 33 (1), 26-36, 2019 | 29 | 2019 |
| Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia S Stasik, JN Eckardt, M Kramer, C Röllig, A Krämer, S Scholl, A Hochhaus, ... Blood advances 5 (17), 3279-3289, 2021 | 28 | 2021 |
| Microbial communities in oil sands tailings: their implications in biogeochemical processes and tailings management T Siddique, S Stasik, MF Mohamad Shahimin, K Wendt-Potthoff Microbial Communities Utilizing Hydrocarbons and Lipids: Members …, 2018 | 26 | 2018 |
| Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations JN Eckardt, F Stölzel, D Kunadt, C Röllig, S Stasik, L Wagenführ, ... Journal of Hematology & Oncology 15 (1), 60, 2022 | 24 | 2022 |
| Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment R Teipel, F Kroschinsky, M Kramer, T Kretschmann, K Egger-Heidrich, ... Blood advances 6 (6), 1941-1946, 2022 | 24 | 2022 |
| Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study JM Middeke, KH Metzeler, C Röllig, M Krämer, JN Eckardt, S Stasik, ... Blood advances 6 (5), 1394-1405, 2022 | 21 | 2022 |
| Clinical challenges and consequences of measurable residual disease in non-APL acute myeloid leukemia M Jentzsch, S Schwind, E Bach, S Stasik, C Thiede, U Platzbecker Cancers 11 (11), 1625, 2019 | 20 | 2019 |
| Disposal of waste materials at the bottom of pit lakes M Schultze, B Boehrer, K Friese, M Koschorreck, S Stasik, ... Mine Closure 2011: Proceedings of the Sixth International Conference on Mine …, 2011 | 19 | 2011 |
| Overlapping features of therapy-related and de novo NPM1-mutated AML J Othman, M Meggendorfer, E Tiacci, C Thiede, R Schlenk, R Dillon, ... Blood 141 (15), 1846-1857, 2023 | 17 | 2023 |
| Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML S Stasik, C Burkhard-Meier, M Kramer, JM Middeke, U Oelschlaegel, ... Blood Advances 6 (11), 3294-3303, 2022 | 17 | 2022 |
Christian ThiedeProfessor of Molecular Hematology, University of Technics DresdenVerified email at uniklinikum-dresden.de
